Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
It is the first autotaxin inhibitor to be investigated in cancer patients
Vision loss due to Glaucoma can be prevented if it is detected and treated early
The validations confirm the completion of the applications and commence the scientific review process
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
Connecting new production and consumption areas of chilled food by low-carbon transportation services
Launch of Indian public health standards for Ayush healthcare facilities
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
Subscribe To Our Newsletter & Stay Updated
